EUVIMEDEUVIMED entdecken
Crossref

CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity

Yanping Luo, Yunxuan Lei, Xin Guo, Dehao Zhu, Haiyang Zhang, Zizhen Guo, Zichong Xu, Hanqing Zhao, Yebin Xi, Xiaochun Peng, Lianbo Xiao, Zhaojun Wang und 2 weitere

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yanping Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China. Hauptthemen laut MEDLINE: Synoviocytes, Arthritis, Rheumatoid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health and Family Planning Commission of Sichuan Province, Shanghai Municipal Commission of Health and Family Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast-like synoviocytes (FLS) mediate many pathological processes in rheumatoid arthritis (RA), including pannus formation, bone erosion, and inflammation. RA FLS have unique aggressive phenotypes and exhibit several tumor cell-like characteristics, including hyperproliferation, excessive migration and invasion. Casein kinase 2 (CK2) is reportedly overexpressed in numerous tumor types, and targeted inhibition of CK2 has therapeutic benefits for tumors. However, the expression level of CK2 and its functions in RA FLS remain unclear. Herein, we aimed to elucidate whether CK2 is responsible for the aggressive phenotypes of RA FLS and whether targeted therapy can alleviate the severity of RA. We found that CK2 subunits were elevated in RA FLS compared with osteoarthritis FLS, and the activity of CK2 also markedly increased in RA FLS. Targeted inhibition of CK2 using CX-4945 suppressed RA FLS proliferation through cell cycle arrest. Cell migration and invasion were also inhibited by CX-4945 treatment. Moreover, CX-4945 reduced Interleukin-6 (IL-6), CC motif chemokine ligand 2 (CCL2) and Matrix metalloproteinase-3 (MMP-3) secretion in RA FLS. Further proteomic investigation revealed that p53 signaling pathway significantly changes after CX-4945 treatment in RA FLS. The siRNA-mediated p53 knockdown partly abolished the anti-proliferation and reduced IL-6, MMP-3 secretion effects of CX-4945. Furthermore, CX-4945 administration alleviates arthritis severity in CIA mice. Collectively, our results demonstrated the abnormal elevation of CK2 and its positive association with abnormal phenotypes in RA FLS. Our novel findings suggest the possible therapeutic potential of CX-4945 for RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynoviocytesArthritis, RheumatoidMiceAnimalsCasein Kinase IIMatrix Metalloproteinase 3Tumor Suppressor Protein p53Interleukin-6ProteomicsCell ProliferationCells, CulturedFibroblastsPatient AcuitySynovial MembraneNaphthyridinesPhenazines

Stichwörter der Autor:innen

CX-4945Casein kinase 2Fibroblast-like synoviocytesRheumatoid arthritisp53 signaling pathway

Substanzen

Casein Kinase IIMatrix Metalloproteinase 3Tumor Suppressor Protein p53Interleukin-6silmitasertibNaphthyridinesPhenazines

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China.
  • Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
  • Department of Joint Surgery, Guanghua Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Institute of Arthritis Research in Integrative Medicine, Shanghai Academy of Traditional Chinese Medicin…
  • Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China. Electronic address: zjwang@sjtu.edu.cn.
  • Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China. Electronic address: niuxiaoyin@163.com.
  • Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Shanghai 200025, China. Electronic address: guangjie_chen@163.com.

Förderung

  • National Natural Science Foundation of China
  • Health and Family Planning Commission of Sichuan Province
  • Shanghai Municipal Commission of Health and Family Planning

Zitieren

APA

Luo, Y., Lei, Y., Guo, X., Zhu, D., Zhang, H., Guo, Z., Xu, Z., Zhao, H., Xi, Y., Peng, X., Xiao, L., Wang, Z., Niu, X., & Chen, G. (2023). CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110163

Vancouver

Luo Y, Lei Y, Guo X, Zhu D, Zhang H, Guo Z, et al. CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110163

BibTeX
@article{Luo2023,
  author = {Luo, Yanping and Lei, Yunxuan and Guo, Xin and Zhu, Dehao and Zhang, Haiyang and Guo, Zizhen and Xu, Zichong and Zhao, Hanqing and Xi, Yebin and Peng, Xiaochun and Xiao, Lianbo and Wang, Zhaojun and Niu, Xiaoyin and Chen, Guangjie},
  title = {CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110163}
}
Kostenlos starten →